Quelles sont les complications possibles de l'ostéosarcome ?
Les complications incluent la propagation de la tumeur, des fractures et des effets secondaires du traitement.
OstéosarcomeComplicationsFractures
#2
L'ostéosarcome peut-il se propager à d'autres organes ?
Oui, l'ostéosarcome peut se propager aux poumons et à d'autres parties du corps.
OstéosarcomeMétastasesPoumons
#3
Quels effets secondaires peut-on attendre du traitement ?
Les effets secondaires incluent nausées, fatigue, perte de cheveux et infections.
OstéosarcomeEffets secondairesChimiothérapie
#4
Comment gérer les complications post-chirurgicales ?
La gestion inclut le suivi médical, la rééducation et le contrôle de la douleur.
OstéosarcomeChirurgieRééducation
#5
Les complications affectent-elles le pronostic ?
Oui, les complications peuvent influencer le pronostic et la survie à long terme.
OstéosarcomePronosticSurvie
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque de l'ostéosarcome ?
Les principaux facteurs incluent l'âge, des antécédents familiaux et certaines conditions génétiques.
OstéosarcomeFacteurs de risqueAntécédents familiaux
#2
Le sexe influence-t-il le risque d'ostéosarcome ?
Oui, l'ostéosarcome est plus fréquent chez les garçons que chez les filles.
OstéosarcomeSexeRisque
#3
Les antécédents de cancer augmentent-ils le risque ?
Oui, avoir des antécédents de cancer augmente le risque de développer un ostéosarcome.
OstéosarcomeAntécédents de cancerRisque
#4
Les troubles osseux prédisposent-ils à l'ostéosarcome ?
Oui, certains troubles osseux peuvent augmenter le risque d'ostéosarcome.
OstéosarcomeTroubles osseuxRisque
#5
L'alimentation joue-t-elle un rôle dans le risque ?
Il n'y a pas de lien établi entre l'alimentation et le risque d'ostéosarcome.
OstéosarcomeAlimentationRisque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ostéosarcome : Questions médicales les plus fréquentes",
"headline": "Ostéosarcome : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ostéosarcome : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-01",
"dateModified": "2024-10-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ostéosarcome"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sarcomes",
"url": "https://recherchemedicale.com/mesh/D012509",
"about": {
"@type": "MedicalCondition",
"name": "Sarcomes",
"code": {
"@type": "MedicalCode",
"code": "D012509",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.450.795"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ostéosarcome juxtacortical",
"alternateName": "Osteosarcoma, Juxtacortical",
"url": "https://recherchemedicale.com/mesh/D018217",
"about": {
"@type": "MedicalCondition",
"name": "Ostéosarcome juxtacortical",
"code": {
"@type": "MedicalCode",
"code": "D018217",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.450.795.620.655"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sarcome d'Ewing",
"alternateName": "Sarcoma, Ewing",
"url": "https://recherchemedicale.com/mesh/D012512",
"about": {
"@type": "MedicalCondition",
"name": "Sarcome d'Ewing",
"code": {
"@type": "MedicalCode",
"code": "D012512",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.450.795.620.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ostéosarcome",
"alternateName": "Osteosarcoma",
"code": {
"@type": "MedicalCode",
"code": "D012516",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Stefan S Bielack",
"url": "https://recherchemedicale.com/author/Stefan%20S%20Bielack",
"affiliation": {
"@type": "Organization",
"name": "Pediatric Oncology, Hematology, Immunology, Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Stuttgart, Germany."
}
},
{
"@type": "Person",
"name": "Jonathan Gill",
"url": "https://recherchemedicale.com/author/Jonathan%20Gill",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA."
}
},
{
"@type": "Person",
"name": "Richard Gorlick",
"url": "https://recherchemedicale.com/author/Richard%20Gorlick",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. rgorlick@mdanderson.org."
}
},
{
"@type": "Person",
"name": "Claudia Blattmann",
"url": "https://recherchemedicale.com/author/Claudia%20Blattmann",
"affiliation": {
"@type": "Organization",
"name": "Cooperative Osteosarkom-Studiengruppe Gruppe COSS, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Zentrum für Kinder-, Jugend- und Frauenmedizin, Stuttgart Cancer Center, Klinikum Stuttgart - Olgahospital, Stuttgart, Germany."
}
},
{
"@type": "Person",
"name": "Leo Kager",
"url": "https://recherchemedicale.com/author/Leo%20Kager",
"affiliation": {
"@type": "Organization",
"name": "St. Anna Kinderspital, Universitätsklinik für Kinder- und Jugendheilkunde der Medizinischen Universität Wien, and St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Osteosarcoma.",
"datePublished": "2022-12-08",
"url": "https://recherchemedicale.com/article/36481668",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41572-022-00409-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advances in Osteosarcoma.",
"datePublished": "2023-06-17",
"url": "https://recherchemedicale.com/article/37329384",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11914-023-00803-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group.",
"datePublished": "2023-03-17",
"url": "https://recherchemedicale.com/article/36928868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cncr.34744"
}
},
{
"@type": "ScholarlyArticle",
"name": "Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group.",
"datePublished": "2023-02-25",
"url": "https://recherchemedicale.com/article/36842425",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jgo.2023.101445"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality.",
"datePublished": "2022-10-13",
"url": "https://recherchemedicale.com/article/36311748",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.871076"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://recherchemedicale.com/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://recherchemedicale.com/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du tissu conjonctif et des tissus mous",
"item": "https://recherchemedicale.com/mesh/D018204"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sarcomes",
"item": "https://recherchemedicale.com/mesh/D012509"
},
{
"@type": "ListItem",
"position": 6,
"name": "Ostéosarcome",
"item": "https://recherchemedicale.com/mesh/D012516"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ostéosarcome - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ostéosarcome",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-01-22",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ostéosarcome",
"description": "Comment diagnostique-t-on un ostéosarcome ?\nQuels tests sont utilisés pour confirmer l'ostéosarcome ?\nQuels signes indiquent un ostéosarcome ?\nL'ostéosarcome peut-il être confondu avec d'autres maladies ?\nQuel rôle joue l'IRM dans le diagnostic ?",
"url": "https://recherchemedicale.com/mesh/D012516#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ostéosarcome",
"description": "Quels sont les symptômes courants de l'ostéosarcome ?\nLa douleur est-elle constante dans l'ostéosarcome ?\nPeut-on avoir des symptômes sans tumeur visible ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes systémiques associés ?",
"url": "https://recherchemedicale.com/mesh/D012516#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ostéosarcome",
"description": "Peut-on prévenir l'ostéosarcome ?\nY a-t-il des facteurs de risque connus ?\nLes radiations augmentent-elles le risque d'ostéosarcome ?\nLes maladies génétiques influencent-elles le risque ?\nL'activité physique a-t-elle un impact sur le risque ?",
"url": "https://recherchemedicale.com/mesh/D012516#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ostéosarcome",
"description": "Quels traitements sont disponibles pour l'ostéosarcome ?\nLa chimiothérapie est-elle toujours nécessaire ?\nQuel est le rôle de la chirurgie dans le traitement ?\nY a-t-il des traitements expérimentaux pour l'ostéosarcome ?\nComment se déroule la chimiothérapie pour l'ostéosarcome ?",
"url": "https://recherchemedicale.com/mesh/D012516#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ostéosarcome",
"description": "Quelles sont les complications possibles de l'ostéosarcome ?\nL'ostéosarcome peut-il se propager à d'autres organes ?\nQuels effets secondaires peut-on attendre du traitement ?\nComment gérer les complications post-chirurgicales ?\nLes complications affectent-elles le pronostic ?",
"url": "https://recherchemedicale.com/mesh/D012516#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ostéosarcome",
"description": "Quels sont les principaux facteurs de risque de l'ostéosarcome ?\nLe sexe influence-t-il le risque d'ostéosarcome ?\nLes antécédents de cancer augmentent-ils le risque ?\nLes troubles osseux prédisposent-ils à l'ostéosarcome ?\nL'alimentation joue-t-elle un rôle dans le risque ?",
"url": "https://recherchemedicale.com/mesh/D012516#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un ostéosarcome ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des examens d'imagerie, comme la radiographie et l'IRM, suivis d'une biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer l'ostéosarcome ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie et une biopsie osseuse sont essentiels pour confirmer la présence d'ostéosarcome."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un ostéosarcome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleur osseuse persistante, gonflement et parfois fractures pathologiques peuvent indiquer un ostéosarcome."
}
},
{
"@type": "Question",
"name": "L'ostéosarcome peut-il être confondu avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec d'autres tumeurs osseuses ou des infections osseuses."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'IRM dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM aide à évaluer l'étendue de la tumeur et à planifier le traitement chirurgical."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'ostéosarcome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur osseuse, gonflement, fatigue et parfois fièvre."
}
},
{
"@type": "Question",
"name": "La douleur est-elle constante dans l'ostéosarcome ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur peut être intermittente au début, mais devient souvent constante avec le temps."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans tumeur visible ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs et des gonflements peuvent survenir avant qu'une tumeur ne soit visible."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les adolescents peuvent présenter des symptômes plus aigus que les adultes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la perte de poids et la fatigue peuvent également être présents."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'ostéosarcome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique pour l'ostéosarcome."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs de risque connus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent des antécédents familiaux, certaines maladies génétiques et l'âge."
}
},
{
"@type": "Question",
"name": "Les radiations augmentent-elles le risque d'ostéosarcome ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux radiations peut augmenter le risque de développer un ostéosarcome."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques influencent-elles le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies comme le syndrome de Li-Fraumeni augmentent le risque d'ostéosarcome."
}
},
{
"@type": "Question",
"name": "L'activité physique a-t-elle un impact sur le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'y a pas de preuve claire que l'activité physique réduit le risque d'ostéosarcome."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'ostéosarcome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut la chirurgie, la chimiothérapie et parfois la radiothérapie."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie est souvent utilisée pour réduire la taille de la tumeur avant la chirurgie."
}
},
{
"@type": "Question",
"name": "Quel est le rôle de la chirurgie dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie vise à retirer complètement la tumeur et à préserver autant que possible le tissu sain."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour l'ostéosarcome ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques testent de nouvelles thérapies ciblées et immunothérapies."
}
},
{
"@type": "Question",
"name": "Comment se déroule la chimiothérapie pour l'ostéosarcome ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chimiothérapie se fait généralement en cycles, avec des médicaments administrés par voie intraveineuse."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'ostéosarcome ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la propagation de la tumeur, des fractures et des effets secondaires du traitement."
}
},
{
"@type": "Question",
"name": "L'ostéosarcome peut-il se propager à d'autres organes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'ostéosarcome peut se propager aux poumons et à d'autres parties du corps."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peut-on attendre du traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent nausées, fatigue, perte de cheveux et infections."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications post-chirurgicales ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut le suivi médical, la rééducation et le contrôle de la douleur."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le pronostic ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent influencer le pronostic et la survie à long terme."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de l'ostéosarcome ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'âge, des antécédents familiaux et certaines conditions génétiques."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque d'ostéosarcome ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'ostéosarcome est plus fréquent chez les garçons que chez les filles."
}
},
{
"@type": "Question",
"name": "Les antécédents de cancer augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de cancer augmente le risque de développer un ostéosarcome."
}
},
{
"@type": "Question",
"name": "Les troubles osseux prédisposent-ils à l'ostéosarcome ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles osseux peuvent augmenter le risque d'ostéosarcome."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'y a pas de lien établi entre l'alimentation et le risque d'ostéosarcome."
}
}
]
}
]
}
Cooperative Osteosarkom-Studiengruppe Gruppe COSS, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Zentrum für Kinder-, Jugend- und Frauenmedizin, Stuttgart Cancer Center, Klinikum Stuttgart - Olgahospital, Stuttgart, Germany.
St. Anna Kinderspital, Universitätsklinik für Kinder- und Jugendheilkunde der Medizinischen Universität Wien, and St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Cooperative Osteosarkom-Studiengruppe Gruppe COSS, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Zentrum für Kinder-, Jugend- und Frauenmedizin, Stuttgart Cancer Center, Klinikum Stuttgart - Olgahospital, Stuttgart, Germany.
Cooperative Osteosarkom-Studiengruppe Gruppe COSS, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Zentrum für Kinder-, Jugend- und Frauenmedizin, Stuttgart Cancer Center, Klinikum Stuttgart - Olgahospital, Stuttgart, Germany.
Klinikum Stuttgart-Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend-, und Frauenmedizin, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Stuttgart, Germany.
Klinikum Stuttgart-Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend-, und Frauenmedizin, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Stuttgart, Germany.
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in males. The key pathophysiolog...
This article gives a brief overview of the most recent developments in osteosarcoma treatment, including targeting of signaling pathways, immune checkpoint inhibitors, drug delivery strategies as sing...
Osteosarcoma is one of the most common primary malignant bone tumors in children and young adults, with a high risk of bone and lung metastases and a 5-year survival rate around 70% in the absence of ...
Primary rib osteosarcoma has not been investigated extensively, and clinical characteristics and optimal therapeutic strategies have not been defined. The authors used the database of the Cooperative ...
The COSS database was searched for treatment-naive, high-grade osteosarcomas of the rib. Affected patients were analyzed for demographic and tumor-related factors, treatments, and outcomes....
A total of 44 patients (23 males, 21 females; median age, 23 years [range, 6-59]) were identified. Primary metastases were detected in six of 44 (14%) patients. Surgery was performed in 40 of 44 (91%)...
This large series provides evidence that patients with costal primaries are older than the average osteosarcoma patient, but appear to share the similar tumor biology and-if treated according to stand...
Osteosarcoma is typically a disease of the young, but may affect any age. Little is known about the disease in older patients beyond retirement age. We aim to describe the characteristics, treatment, ...
The database of the Cooperative Osteosarcoma Study Group (COSS) was searched for osteosarcoma patients diagnosed from 1980 to 2020 who were aged 65 years or older at diagnosis. Affected individuals we...
Fifty-five eligible patients were detected (median age 68 [range: 65-84] years; male:female = 25:30). Among these patients, 15/55 (27%) tumors were secondary malignancies, 41/55 (75%) were high-grade ...
Osteosarcomas can occur in older individuals. It is more often secondary, axially located, or extraosseous than in younger patients. However, the same treatment principles seem to apply, and selected ...
Osteosarcoma (OS) is one of the most common primary malignant tumors originating in bones. Its high malignancy typically manifests in lung metastasis leading to high mortality. Although remarkable adv...
Chondroblastoma-like osteosarcoma (CBLOS) is a rare and poorly understood variant of OS. We examined the clinicopathological, immunohistochemical and molecular features of six CBLOSs to highlight the ...
We performed histone 3.3 mutation analysis by gene sequencing and/or immunohistochemistry in all cases, while whole exome sequencing (WES) was performed on two CB-like osteosarcomas and 11 conventiona...
CBLOSs were predominantly localised at acral sites and involved mainly male subjects with a mean age of 29 years. One patient who had metastases at presentation died of disease, while another patient ...
CBLOS presents a different genetic background and a less aggressive clinical behaviour in comparison with CHGOS. Search of the H3F3B K36M mutation is useful in the differential diagnosis with CB....
Primary osteosarcomas are rarely seen in areas other than bone, although they can occur in sites such as the thigh, anal region, hand, etc. We present a case of primary extraskeletal osteosarcoma of t...
Osteosarcoma (OS) is the most prevalent and fatal type of bone tumor. It is characterized by great heterogeneity of genomic aberrations, mutated genes, and cell types contribution, making therapy and ...
Osteosarcoma has become the most common bone malignancy in adolescents. Although the clinical treatment of osteosarcoma has advanced considerably in recent years, the 5-year survival rate has not impr...
We selected prognostic genes that are closely associated with osteosarcoma clinical features by obtaining osteosarcoma patient information from the GTEx and TARGET databases, and then we developed a r...
In conclusion, we validated that the prognostic factor FKBP11 is closely associated with osteosarcoma. Additionally, we identified a novel mechanism by which FKBP11 ameliorates the malignant propertie...
There is no clear consensus guideline that specifies the optimum course of treatment for adult head and neck osteosarcoma (HNO) because of its rarity. The review's goal is to examine the most recent r...
Due to overlapping symptoms with various benign disorders of the lower jaw and midface bone, these patients present with a noticeable delay. The greatest results for these malignancies can be achieved...
Multimodality treatments seem to yield better results for advanced HNO with adverse features and incomplete resections....